1
Comments on the strategy for:
The Promotion of Sexual and Reproductive Health and Rights
By Jens Byskov, DBL-Institute for Health Research and Development. 12.01 2006
Comments are in English as is the case for the document. Comments and statements can
be referred to or used as desired for the final version of the strategy.
____________________________________________________________________
Background
The UM web site introduces the document as based on a 2004 Government decision to
develop a new strategy for Denmarks support within the areas of population and health
with a particular focus on women and the link and coordination between prevention of
HIV/AIDS and Sexual and Reproductive Health and Rights (SRHR).
This puts the document into a wider context than just SRHR as e.g. the Ministry of
Foreign Affairs Health Sector Policy of 1995 remains valid in principle. A number of
other strategies, guidelines and papers have since interpreted such policies or given new
direction in the areas of health and population. These include amongst other documents
on sector program development and financing, a discussion paper on the a Danish
perspective concerning assistance to the Health Sector, area and cross cutting specific
documents such as the Africa Policy as well as those on gender issues and HIV/AIDS.
Poverty Reduction strategies have provided broader framework and new direction to
development efforts, also within Health.
The MDG and global focus
The document is much tuned to getting its justification from and to assisting in achieving
the Millennium Development Goals. These provide a direction for developments and
include 3 goals for health outcomes among the total of 8 Goals. Reference is made to
goals 3 for gender, 5 for maternal health and 6 for HIV/AIDS, malaria and other diseases.
Goal 4 concerning reduction in child mortality could be included as well, as the
document repeatedly argues the case for improved health of children as a necessary part
of support for SRHR. MDG Targets and indicators within MDG 3,4,5 and 6 include a
majority of health outcome measures, but fortunately also a number of output areas. The
extensive reference to the MDGs is important, but also an inherent weakness of the
strategy as MDGs do not easily translate into the most important output or assign
concrete responsibilities to select the most important products (output, results) needed to
achieve them or the underlying relevant activities and the input (resources, money)
needed to produce them.